References
- Abbott NJ, Patabendige AA, Dolman DE, et al. (2010). Structure and function of the blood–brain barrier. Neurobiol Dis 37:13–25
- Aboitiz F, Scheibel AB, Fisher RS, Zaidel E. (1992). Fiber composition of the human corpus callosum. Brain Res 598:143–53
- Amstalden van Hove ER, Smith DF, Heeren RMA. (2010). A concise review of mass spectrometry imaging. J Chromatogr A 1217:3946–54
- Bratkowska D, Shobo A, Singh S, et al. (2015). Determination of the antitubercular drug PA-824 in rat plasma, lung and brain tissues by liquid chromatography tandem mass spectrometry: application to a pharmacokinetic study. J Chromatogr B 988:187–94
- Castellino S. (2012). MALDI imaging MS analysis of drug distribution in tissue: the right time!(?). Bioanalysis 4:2549–51
- Dartois V. (2014). The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells. Nat Rev Microbiol 12:159–67
- Denny WA, Palmer BD. (2010). The nitroimidazooxazines (PA-824 and analogs): structure-activity relationship and mechanistic studies. Future Med Chem 2:1295–304
- Heeren R. (2014). Getting the picture: the coming of age of imaging MS. Int J Mass Spectrom 279:136–46
- Himmelsbach M. (2012). 10years of MS instrumental developments–impact on LC–MS/MS in clinical chemistry. J Chromatogr B 883:3–17
- Kaneko R, Wada Y. (2003). Decomposition of protein nitrosothiolsin matrix-assisted laser desorption/ionization and electrospray ionization mass spectrometry. J Mass Spectrom 38:526–30
- Lakshminarayana SB, Boshoff HIM, Cherian J, et al. (2014). Pharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosis. PLoS One 9:e105222
- Lenaerts AJ, Gruppo V, Marietta KS, et al. (2005). Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models. Antimicrob Agents Chemother 49:2294–301
- Levsen K, Schiebel HM, Terlouw JK, et al. (2007). Even-electron ions: a systematic study of the neutral species lost in the dissociation of quasi-molecular ions. J Mass Spectrom 42:1024–44
- Liu L, Xu Y, Shea C, et al. (2010). Radiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin and pyrazinamide in baboons. J Med Chem 53:2882–91
- Manjunatha U, Boshoff HIM, Barry CE. (2009). The mechanism of action of PA-824. Commun Integr Biol 2:215–18
- Matthews PM, Rabiner EA, Passchier J, Gunn RN. (2012). Positron emission tomography molecular imaging for drug development. Br J Clin Pharmacol 73:175–86
- McDonnell LA, Römpp A, Balluff B, et al. (2014). Discussion point: reporting guidelines for mass spectrometry imaging. Anal Bioanal Chem 407:2035–45
- Mindermann T, Landolt H, Zimmerli W, et al. (1993). Penetration of rifampicin into the brain tissue and cerebral extracellular space of rats. J Antimicrob Chemother 31:731–7
- Nau R, Sörgel F, Eiffert H. (2010). Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 23:858–83
- Prideaux B, Stoeckli M. (2012). Mass spectrometry imaging for drug distribution studies. J Proteomics 75:4999–5013
- Shobo A, Bratkowska D, Baijnath S, et al. (2015). Visualization of time-dependent distribution of rifampicin in rat brain using MALDI MSI and quantitative LCMS/MS. Assay Drug Dev Technol 13:277–84
- Solon EG. (2012). Use of radioactive compounds and autoradiography to determine drug tissue distribution. Chem Res Toxicol 25:543–55
- Stumpf WE. (2013). Whole-body and microscopic autoradiography to determine tissue distribution of biopharmaceuticals: target discoveries with receptor micro-autoradiography engendered new concepts and therapies for vitamin D. Adv Drug Deliv Rev 65:1086–97
- Svatoš A. (2010). Mass spectrometric imaging of small molecules. Trends Biotechnol 28:425–34
- Tasneen R, Williams K, Amoabeng O, et al. (2015). Contribution of the nitroimidazoles PA-824 and TBA-354 to the activity of novel regimens in murine models of tuberculosis. Antimicrob Agents Chemother 59:129–35
- Wang L, Xu Y, Liang L, et al. (2014). LC–MS/MS method for the simultaneous determination of PA-824, moxifloxacin and pyrazinamide in rat plasma and its application to pharmacokinetic study. J Pharm Biomed Anal 97:1–8
- Williams K, Minkowski A, Amoabeng O, et al. (2012). Sterilizing activities of novel combinations lacking first-and second-line drugs in a murine model of tuberculosis. Antimicrob Agents Chemother 56:3114–20
- Wong EB, Cohen KA, Bishai WR. (2013). Rising to the challenge: new therapies for tuberculosis. Trends Microbiol 21:493–501
- World Health Organization (WHO). (2014). Antimicrobial resistance: global report on surveillance. Report from World Health Organization
- Zumla A, Nahid P, Cole ST. (2013). Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov 12:388–404